Solti-1907 Atrezzo: Targeting Hormonal Receptor Negative (Hr-) Or Pam50 Non-Luminal Disease With Atezolizumab In Combination With Trastuzumab And Vinorelbine In Her2+Metastatic Breast Cancer (Mbc)

ANNALS OF ONCOLOGY(2021)

引用 0|浏览10
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要